MMPW
CELG

Mitchell McLeod Pugh & Williams’s Celgene Corp CELG Stock Holding History

Mitchell McLeod Pugh & Williams’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,870
Closed -$583K – 177
2019
Q3 		$583K Hold
5,870
– – 0.4% 90
2019
Q2 		$543K Sell
5,870
-500
-8% -$47.5K 0.37% 97
2019
Q1 		$601K Hold
6,370
– – 0.42% 85
2018
Q4 		$408K Hold
6,370
– – 0.33% 109
2018
Q3 		$570K Sell
6,370
-20
-0.3% -$1.77K 0.38% 89
2018
Q2 		$507K Buy
6,390
+20
+0.3% +$1.66K 0.36% 102
2018
Q1 		$568K Hold
6,370
– – 0.41% 90
2017
Q4 		$665K Hold
6,370
– – 0.46% 80
2017
Q3 		$929K Sell
6,370
-380
-6% -$51.8K 0.68% 49
2017
Q2 		$877K Hold
6,750
– – 0.67% 52
2017
Q1 		$840K Hold
6,750
– – 0.66% 53
2016
Q4 		$781K Hold
6,750
– – 0.63% 57
2016
Q3 		$706K Hold
6,750
– – 0.62% 59
2016
Q2 		$666K Hold
6,750
– – 0.6% 62
2016
Q1 		$676K Hold
6,750
– – 0.65% 54
2015
Q4 		$808K Hold
6,750
– – 0.8% 40
2015
Q3 		$730K Hold
6,750
– – 0.75% 45
2015
Q2 		$781K Hold
6,750
– – 0.72% 46
2015
Q1 		$778K Hold
6,750
– – 0.71% 47
2014
Q4 		$755K Buy
+6,750
New +$712K 0.7% 49

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Mitchell McLeod Pugh & Williams's CELG Position: Q4 2019 in Review

Mitchell McLeod Pugh & Williams sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,870 shares — an estimated $583K sold.

Mitchell McLeod Pugh & Williams first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $929K in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Mitchell McLeod Pugh & Williams reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Mitchell McLeod Pugh & Williams sold 5,870 Celgene Corp shares in Q4 2019, an estimated $583K.
  • Mitchell McLeod Pugh & Williams first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • Mitchell McLeod Pugh & Williams's Celgene Corp position peaked at $929K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q4 2019, filed 8 Jan 2020.